메뉴 건너뛰기




Volumn 59, Issue 3, 2008, Pages 209-218

Breast cancer risk in postmenopausal women using testosterone in combination with hormone replacement therapy

Author keywords

Breast cancer risk; Exogenous testosterone; Oestrogen testosterone combination therapy; Postmenopausal patients; Review

Indexed keywords

ANDROGEN; CONJUGATED ESTROGEN; ESTRADIOL; ESTRATEST; ESTROGEN; ESTRONE SULFATE; GESTAGEN; MEDROXYPROGESTERONE ACETATE; METHYLTESTOSTERONE; NORETHISTERONE ACETATE; TESTOSTERONE;

EID: 43049117819     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.01.005     Document Type: Review
Times cited : (20)

References (34)
  • 1
    • 0034457514 scopus 로고    scopus 로고
    • A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition
    • Burger H.G., Dudley E.C., Cui J., Dennerstein L., and Hopper J.L. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 85 August (8) (2000) 2832-2838
    • (2000) J Clin Endocrinol Metab , vol.85 , Issue.August 8 , pp. 2832-2838
    • Burger, H.G.1    Dudley, E.C.2    Cui, J.3    Dennerstein, L.4    Hopper, J.L.5
  • 2
    • 0028945598 scopus 로고
    • Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women
    • Zumoff B., Strain G.W., Miller L.K., and Rosner W. Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab 80 April (4) (1995) 1429-1430
    • (1995) J Clin Endocrinol Metab , vol.80 , Issue.April 4 , pp. 1429-1430
    • Zumoff, B.1    Strain, G.W.2    Miller, L.K.3    Rosner, W.4
  • 4
    • 0033054402 scopus 로고    scopus 로고
    • Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women
    • Simon J., Klaiber E., Wiita B., Bowen A., and Yang H.M. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women. Menopause 6 2 (1999) 138-146
    • (1999) Menopause , vol.6 , Issue.2 , pp. 138-146
    • Simon, J.1    Klaiber, E.2    Wiita, B.3    Bowen, A.4    Yang, H.M.5
  • 5
    • 0033304561 scopus 로고    scopus 로고
    • Androgen replacement in women: a commentary
    • Davis S. Androgen replacement in women: a commentary. J Clin Endocrinol Metab 84 June (6) (1999) 1886-1891
    • (1999) J Clin Endocrinol Metab , vol.84 , Issue.June 6 , pp. 1886-1891
    • Davis, S.1
  • 6
    • 0033015913 scopus 로고    scopus 로고
    • The therapeutic use of androgens in women
    • Davis S.R. The therapeutic use of androgens in women. J Steroid Biochem Mol Biol 69 April (1-6) (1999) 177-184
    • (1999) J Steroid Biochem Mol Biol , vol.69 , Issue.April 1-6 , pp. 177-184
    • Davis, S.R.1
  • 7
    • 0033540646 scopus 로고    scopus 로고
    • Sexual dysfunction in the United States: prevalence and predictors
    • Laumann E.O., Paik A., and Rosen R.C. Sexual dysfunction in the United States: prevalence and predictors. JAMA 281 February (6) (1999) 537-544
    • (1999) JAMA , vol.281 , Issue.February 6 , pp. 537-544
    • Laumann, E.O.1    Paik, A.2    Rosen, R.C.3
  • 8
    • 33746387475 scopus 로고    scopus 로고
    • Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women
    • Tamimi R.M., Hankinson S.E., Chen W.Y., Rosner B., and Colditz G.A. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Arch Intern Med 166 July (14) (2006) 1483-1489
    • (2006) Arch Intern Med , vol.166 , Issue.July 14 , pp. 1483-1489
    • Tamimi, R.M.1    Hankinson, S.E.2    Chen, W.Y.3    Rosner, B.4    Colditz, G.A.5
  • 9
    • 0024269969 scopus 로고
    • Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells
    • Hackenberg R., Hofmann J., Holzel F., and Schulz K.D. Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells. J Cancer Res Clin Oncol 114 6 (1988) 593-601
    • (1988) J Cancer Res Clin Oncol , vol.114 , Issue.6 , pp. 593-601
    • Hackenberg, R.1    Hofmann, J.2    Holzel, F.3    Schulz, K.D.4
  • 10
    • 0026750895 scopus 로고
    • Effects of dihydrotestosterone and hydroxyflutamide on androgen receptors in cultured human breast cancer cells (EVSA-T)
    • Marugo M., Bernasconi D., Miglietta L., et al. Effects of dihydrotestosterone and hydroxyflutamide on androgen receptors in cultured human breast cancer cells (EVSA-T). J Steroid Biochem Mol Biol 42 June (5) (1992) 547-554
    • (1992) J Steroid Biochem Mol Biol , vol.42 , Issue.June 5 , pp. 547-554
    • Marugo, M.1    Bernasconi, D.2    Miglietta, L.3
  • 11
    • 0038786584 scopus 로고    scopus 로고
    • A physiologic role for testosterone in limiting estrogenic stimulation of the breast
    • Dimitrakakis C., Zhou J., Wang J., et al. A physiologic role for testosterone in limiting estrogenic stimulation of the breast. Menopause 10 July (4) (2003) 292-298
    • (2003) Menopause , vol.10 , Issue.July 4 , pp. 292-298
    • Dimitrakakis, C.1    Zhou, J.2    Wang, J.3
  • 12
    • 0036252154 scopus 로고    scopus 로고
    • Testosterone and 5 alpha-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines
    • Ortmann J., Prifti S., Bohlmann M.K., Rehberger-Schneider S., Strowitzki T., and Rabe T. Testosterone and 5 alpha-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines. Gynecol Endocrinol 16 April (2) (2002) 113-120
    • (2002) Gynecol Endocrinol , vol.16 , Issue.April 2 , pp. 113-120
    • Ortmann, J.1    Prifti, S.2    Bohlmann, M.K.3    Rehberger-Schneider, S.4    Strowitzki, T.5    Rabe, T.6
  • 13
    • 0024264118 scopus 로고
    • Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line
    • Poulin R., Baker D., and Labrie F. Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res Treat 12 October (2) (1988) 213-225
    • (1988) Breast Cancer Res Treat , vol.12 , Issue.October 2 , pp. 213-225
    • Poulin, R.1    Baker, D.2    Labrie, F.3
  • 14
    • 33750336566 scopus 로고    scopus 로고
    • The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells
    • Krämer E., Seeger H., Krämer B., Wallwiener D., and Mueck A.O. The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells. Eur J Obstet Reprod Biol 129 (2006) 77-83
    • (2006) Eur J Obstet Reprod Biol , vol.129 , pp. 77-83
    • Krämer, E.1    Seeger, H.2    Krämer, B.3    Wallwiener, D.4    Mueck, A.O.5
  • 15
    • 34247643957 scopus 로고    scopus 로고
    • Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in post menopausal women
    • Hofling M., Lindén Hirschberg A., Skoog L., Tan I.E., Hägerström T., and von Schoultz B. Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in post menopausal women. Menopause 14 (2007) 183-190
    • (2007) Menopause , vol.14 , pp. 183-190
    • Hofling, M.1    Lindén Hirschberg, A.2    Skoog, L.3    Tan, I.E.4    Hägerström, T.5    von Schoultz, B.6
  • 16
    • 8644236707 scopus 로고    scopus 로고
    • Postmenopausal testosterone therapy and breast cancer risk
    • Somboonporn W., and Davis S.R. Postmenopausal testosterone therapy and breast cancer risk. Maturitas 49 December (4) (2004) 267-275
    • (2004) Maturitas , vol.49 , Issue.December 4 , pp. 267-275
    • Somboonporn, W.1    Davis, S.R.2
  • 17
    • 0029914622 scopus 로고    scopus 로고
    • Assessing the quality of reports of randomized clinical trials: is blinding necessary?
    • Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
    • (1996) Control Clin Trials , vol.17 , pp. 1-12
    • Jadad, A.R.1    Moore, R.A.2    Carroll, D.3
  • 18
    • 0022978910 scopus 로고
    • Menopausal oestrogens and breast cancer risk: an expanded case-control study
    • Brinton L.A., Hoover R., and Fraumeni Jr. J.F. Menopausal oestrogens and breast cancer risk: an expanded case-control study. Br J Cancer 54 November (5) (1986) 825-832
    • (1986) Br J Cancer , vol.54 , Issue.November 5 , pp. 825-832
    • Brinton, L.A.1    Hoover, R.2    Fraumeni Jr., J.F.3
  • 19
    • 0021184091 scopus 로고
    • The relationship of exogenous estrogens to cancer risk
    • Brinton L.A. The relationship of exogenous estrogens to cancer risk. Cancer Detect Prev 7 3 (1984) 159-171
    • (1984) Cancer Detect Prev , vol.7 , Issue.3 , pp. 159-171
    • Brinton, L.A.1
  • 20
    • 0024243219 scopus 로고
    • Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark
    • Ewertz M. Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark. Int J Cancer 42 6 (1988) 832-838
    • (1988) Int J Cancer , vol.42 , Issue.6 , pp. 832-838
    • Ewertz, M.1
  • 21
    • 0029056755 scopus 로고
    • The use of estrogens and progestins and the risk of breast cancer in postmenopausal women
    • Colditz G.A., Hankinson S.E., Hunter D.J., et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332 24 (1995) 1589-1593
    • (1995) N Engl J Med , vol.332 , Issue.24 , pp. 1589-1593
    • Colditz, G.A.1    Hankinson, S.E.2    Hunter, D.J.3
  • 22
    • 14944359093 scopus 로고    scopus 로고
    • Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy
    • Dimitrakakis C., Jones R.A., Liu A., and Bondy C.A. Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy. Menopause 11 September (5) (2004) 531-535
    • (2004) Menopause , vol.11 , Issue.September 5 , pp. 531-535
    • Dimitrakakis, C.1    Jones, R.A.2    Liu, A.3    Bondy, C.A.4
  • 23
    • 0242500001 scopus 로고    scopus 로고
    • Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology
    • Conner P., Söderqvist G., Skoog L., et al. Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology. Breast Cancer Res Treat 78 (2003) 159-165
    • (2003) Breast Cancer Res Treat , vol.78 , pp. 159-165
    • Conner, P.1    Söderqvist, G.2    Skoog, L.3
  • 24
    • 1642401373 scopus 로고    scopus 로고
    • A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolone and continuous combined estrogen-progestogen treatment
    • Conner P., Christow A., Kersemaekers W., et al. A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolone and continuous combined estrogen-progestogen treatment. Climateric 7 (2004) 50-58
    • (2004) Climateric , vol.7 , pp. 50-58
    • Conner, P.1    Christow, A.2    Kersemaekers, W.3
  • 25
    • 0035124479 scopus 로고    scopus 로고
    • Effects of oral contraceptives on breast epithelial proliferation
    • Isaksson E., von Schoultz E., Odlind V., et al. Effects of oral contraceptives on breast epithelial proliferation. Breast Cancer Res Treat 65 (2001) 163-169
    • (2001) Breast Cancer Res Treat , vol.65 , pp. 163-169
    • Isaksson, E.1    von Schoultz, E.2    Odlind, V.3
  • 26
    • 0037205898 scopus 로고    scopus 로고
    • Breast cancer: from estrogen to androgen receptor
    • Ando S., De A.F., Rago V., et al. Breast cancer: from estrogen to androgen receptor. Mol Cell Endocrinol 193 July (1-2) (2002) 121-128
    • (2002) Mol Cell Endocrinol , vol.193 , Issue.July 1-2 , pp. 121-128
    • Ando, S.1    De, A.F.2    Rago, V.3
  • 27
    • 0034622208 scopus 로고    scopus 로고
    • Effects of an oral contraceptive combination with or without androgen on mammary tissues: a study in rats
    • Jayo M.J., Register T.C., Hughes C.L., et al. Effects of an oral contraceptive combination with or without androgen on mammary tissues: a study in rats. J Soc Gynecol Investig 7 4 (2000) 257-265
    • (2000) J Soc Gynecol Investig , vol.7 , Issue.4 , pp. 257-265
    • Jayo, M.J.1    Register, T.C.2    Hughes, C.L.3
  • 28
    • 0033011090 scopus 로고    scopus 로고
    • Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells
    • Kandouz M., Lombet A., Perrot J.Y., et al. Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells. J Steroid Biochem Mol Biol 69 April (1-6) (1999) 463-471
    • (1999) J Steroid Biochem Mol Biol , vol.69 , Issue.April 1-6 , pp. 463-471
    • Kandouz, M.1    Lombet, A.2    Perrot, J.Y.3
  • 29
    • 0032894681 scopus 로고    scopus 로고
    • Androgens down-regulate bcl-2 protooncogene expression in ZR-75-1 human breast cancer cells
    • Lapointe J., Fournier A., Richard V., and Labrie C. Androgens down-regulate bcl-2 protooncogene expression in ZR-75-1 human breast cancer cells. Endocrinology 140 January (1) (1999) 416-421
    • (1999) Endocrinology , vol.140 , Issue.January 1 , pp. 416-421
    • Lapointe, J.1    Fournier, A.2    Richard, V.3    Labrie, C.4
  • 30
    • 0036126095 scopus 로고    scopus 로고
    • Roles of androgens in the development, growth, and carcinogenesis of the mammary gland
    • Liao D.J., and Dickson R.B. Roles of androgens in the development, growth, and carcinogenesis of the mammary gland. J Steroid Biochem Mol Biol 80 February (2) (2002) 175-189
    • (2002) J Steroid Biochem Mol Biol , vol.80 , Issue.February 2 , pp. 175-189
    • Liao, D.J.1    Dickson, R.B.2
  • 31
    • 0028856381 scopus 로고
    • Proportion of breast cancer cases in the United States explained by well-established risk factors
    • Madigan M.P., Ziegler R.G., Benichou J., Byrne C., and Hoover R.N. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 87 November (22) (1995) 1681-1685
    • (1995) J Natl Cancer Inst , vol.87 , Issue.November 22 , pp. 1681-1685
    • Madigan, M.P.1    Ziegler, R.G.2    Benichou, J.3    Byrne, C.4    Hoover, R.N.5
  • 33
    • 18844458270 scopus 로고    scopus 로고
    • Clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group
    • Kenemans P., and Speroff L. Clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group. Maturitas 51 (2005) 21-28
    • (2005) Maturitas , vol.51 , pp. 21-28
    • Kenemans, P.1    Speroff, L.2
  • 34
    • 33845622057 scopus 로고    scopus 로고
    • 5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production
    • Suzuki T., Miki Y., Moriya T., et al. 5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production. Int J Cancer 120 January (2) (2007) 285
    • (2007) Int J Cancer , vol.120 , Issue.January 2 , pp. 285
    • Suzuki, T.1    Miki, Y.2    Moriya, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.